We are live on ! Find out more
DCI

Data Collective IV Portfolio holdings

AUM $55.9M
1-Year Est. Return 49.14%
This Fund
S&P 500
This Quarter Est. Return
-35.07%
1 Year Est. Return
+49.14%
3 Year Est. Return
+250.98%
5 Year Est. Return
10 Year Est. Return
AUM
$471M
AUM Growth
-$270M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 79.65%
2 Industrials 10.97%
3 Healthcare 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMBK
1
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$375M 79.65%
3,186,008
RXRX icon
2
Recursion Pharmaceuticals
RXRX
$1.62B
$42.5M 9.03%
5,941,120
EVLV icon
3
Evolv Technologies
EVLV
$1.01B
$28.1M 5.96%
10,601,281
RKLB icon
4
Rocket Lab Corp
RKLB
$39.9B
$23.6M 5%
2,929,350
DFTX
5
Definium Therapeutics
DFTX
$5.57B
$1.67M 0.35%
100,350

Similar funds

Data Collective IV's Q1 2022 Portfolio in Review

As of Q1 2022, Data Collective IV held 5 positions worth $471M, down 36% from $741M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Data Collective IV opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 80% of assets, up from 75% a quarter earlier, followed by Industrials and Healthcare.

  • Data Collective IV's ten largest holdings make up 100% of its $471M portfolio in Q1 2022.
  • Data Collective IV opened 0 new positions and closed 0 in Q1 2022.
  • Data Collective IV's portfolio value fell 36% quarter-over-quarter to $471M.

Based on Data Collective IV's 13F filing for Q1 2022, filed 14 Nov 2022.